. 2022 Aug 15;37(6):e370601. doi: 10.1590/acb370601

Table 1. Protein relative expression levels (x ± standard deviation, p)^*.

	Control group	DN group	Low-dose GEN group	High-dose GEN group
NOX4	1.00 ± 0.05	2.21 ± 0.04^***, 0.000	2.00 ± 0.08^##, 0.001	1.67 ± 0.02^### ^@@@, 0.000
mfn2	1.00 ± 0.04	1.48 ± 0.03^***, 0.000	1.82 ± 0.04^###, 0.000	2.33 ± 0.08^### ^@@@, 0.000
p38	1.00 ± 0.08	2.63 ± 0.04^***, 0.000	2.29 ± 0.07^###, 0.000	2.00 ± 0.08^### ^@@@, 0.000
p65	1.00 ± 0.07	2.39 ± 0.01^***, 0.000	1.86 ± 0.03^###, 0.000	1.57 ± 0.03^### ^@@@, 0.000
p53	0.99 ± 0.06	3.08 ± 0.04^***, 0.000	2.52 ± 0.04^###, 0.000	2.21 ± 0.80^### ^@@@, 0.000

DN: diabetic nephropathy; GEN: genistein;

values are expressed as mean ± standard deviation, n = 5 per group;

^***

p < 0.001 vs. control group;

^##

p < 0.01 DN group;

^###

p < 0.001 DN group;

^@@@

p < 0.001 vs. low-dose GEN group.

Table 1. Protein relative expression levels (x ± standard deviation, p)*.